Page last updated: 2024-10-16

gamma-aminobutyric acid and Neuromuscular Junction Diseases

gamma-aminobutyric acid has been researched along with Neuromuscular Junction Diseases in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Neuromuscular Junction Diseases: Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, Q1
Cao, C1
Ding, Y1
So, KF1
Wu, W1
Qu, Y1
Zhou, L1

Other Studies

1 other study available for gamma-aminobutyric acid and Neuromuscular Junction Diseases

ArticleYear
Plasticity of motor network and function in the absence of corticospinal projection.
    Experimental neurology, 2015, Volume: 267

    Topics: Acetylcholine; Animals; Brain Diseases; Cadherins; Choline O-Acetyltransferase; Disease Models, Anim

2015